<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00792779</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE - 0023.0.263.000-08</org_study_id>
    <nct_id>NCT00792779</nct_id>
  </id_info>
  <brief_title>Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty</brief_title>
  <official_title>Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Campinas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Medico Campinas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if propofol could protect erythrocytes by directly
      scavenging free radicals from the blood current and increasing resistance of their cell
      membranes in patients submitted to gastroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Count erythrocytes</measure>
    <time_frame>After 10 hours post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bilirubins(direct and indirect)</measure>
    <time_frame>After 10 hours post-surgery</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hemolysis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Patients in the Propofol Group (PG) will be induced with target-controlled infusion (TCI) of propofol (Diprifusor, AstraZeneca) and remifentanil (Asena PK, Cardinal Health) at the target dose of 6.0 µg.ml-1 and 8.0 ηg.ml-1, respectively. The patients in the Sevoflurane Group (SG) will be induced with remifentanil TCI at target dose of 8.0 ηg.ml-1 and etomidate 0.5 mg.kg-1 in bolus.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients between BMI 40-50 kg/m2

        Exclusion Criteria:

          -  patients with BMI under 40 kg/m2 and over 50 kg/m2

          -  alcohol users

          -  illicit-drug users

          -  patients in regular use of anti-depressants, proton bomb inhibitors or calcium canal
             blockers

          -  patients transfused either recently, during the intra-operative period or within 10
             hours post-operative

          -  patients previously known to be hypersensitive to any drug that is used during the
             study

          -  patients with any psychiatric disorder or dementia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo F Simoni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundação Centro Médico de Campinas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundação Centro Médico de Campinas</name>
      <address>
        <city>Campinas</city>
        <state>São Paulo</state>
        <zip>13084-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med. 2002 Jan 1;165(1):54-60.</citation>
    <PMID>11779730</PMID>
  </results_reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2008</study_first_submitted>
  <study_first_submitted_qc>November 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2008</study_first_posted>
  <last_update_submitted>November 4, 2009</last_update_submitted>
  <last_update_submitted_qc>November 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Francisco Simoni</name_title>
    <organization>Fundação Centro Médico de Campinas</organization>
  </responsible_party>
  <keyword>Morbid obesity</keyword>
  <keyword>General anaesthesia</keyword>
  <keyword>Propofol</keyword>
  <keyword>Sevoflurane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemolysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

